Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians. Lazarus CDS helps clinicians make better decisions when it comes to skin cancer screenings. Lazarus CDS was built with input from dermatologists, patients, and clinical support staff to make sure we have the features that you need most. Not only do our neural networks routinely get dermatologist-level classification accuracy, they also clearly explain every single decision, enabling you, the clinician, to feel truly comfortable with every choice you make. With the presence of human error and a lack of dermoscopy, screening for melanoma over telemedicine platforms is famously difficult. Lazarus CDS bridges the gap by giving you a second opinion to make screening lesions over a photo significantly less risky.
B2B
26 to 50
Funded
$2402000
Scaling Up
2017
Pharmaceuticals and Medical Products
Managed Health Care
Health Care Facilities & Hospitals
Biotechnology
N/A
Healthcare
Increase Efficiency
Analytics
Service
Yes
Active
Machine Learning
Machine Perception
Natural Language Processing
Automated Planning and Search
N/A
Software
N/A
N/A
Potential Customers
Interested in what they do or partnership?
Learn more about how they work